Incidence and implications of idiopathic thrombocytopenia following transcatheter aortic valve replacement with the Edwards Sapien© valves: A single center experience

Catheterization and Cardiovascular Interventions

Volumn 83, Issue 4, 2014, Pages 633-641

  McCabe, James M ^a   Huang, Pei Hsiu ^b   Riedl, Lauren A ^b   Devireddy, Srikanth R ^b   Grondell, Jennifer ^b   Connors, Annie C ^b   Davidson, Michael J ^b   Eisenhauer, Andrew C ^b   Welt, Frederick G P ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

complications adult cath intervention; platelet function; valvular heart disease

Indexed keywords

ADVERSE EFFECTS; AGED; AORTIC VALVE STENOSIS; BLOOD; DEVICES; FEMALE; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HUMAN; INCIDENCE; MALE; MASSACHUSETTS; PROSTHESIS DESIGN; RETROSPECTIVE STUDY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TIME FACTOR; TRANSLUMINAL VALVULOPLASTY; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; BALLOON VALVULOPLASTY; BOSTON; CARDIAC CATHETERIZATION; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INCIDENCE; MALE; PLATELET COUNT; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; THROMBOCYTOPENIA; TIME FACTORS; TREATMENT OUTCOME;

EID: 84894231583     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25206     Document Type: Article

References (20)

1. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S, PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597-1607.
2. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ, PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364: 2187-2198.
3. Makkar RR, Fontana GP, Jilaihawi H, Kapadia S, Pichard AD, Douglas PS, Thourani VH, Babaliaros VC, Webb JG, Herrmann HC, Bavaria JE, Kodali S, Brown DL, Bowers B, Dewey TM, Svensson LG, Tuzcu M, Moses JW, Williams MR, Siegel RJ, Akin JJ, Anderson WN, Pocock S, Smith CR, Leon MB, PARTNER Trial Investigators. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 2012; 366: 1696-1704.
4. Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E, Lefevre T, Himbert D, Tchetche D, Carrié D, Albat B, Cribier A, Rioufol G, Sudre A, Blanchard D, Collet F, Santos Dos P, Meneveau N, Tirouvanziam A, Caussin C, Guyon P, Boschat J, Le Breton H, Collart F, Houel R, Delpine S, Souteyrand G, Favereau X, Ohlmann P, Doisy V, Grollier G, Gommeaux A, Claudel J-P, Bourlon F, Bertrand B, Van Belle E, Laskar M, FRANCE 2 Investigators. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012; 366: 1705-1715.
5. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, Fontana GP, Dewey TM, Thourani VH, Pichard AD, Fischbein M, Szeto WY, Lim S, Greason KL, Teirstein PS, Malaisrie SC, Douglas PS, Hahn RT, Whisenant B, Zajarias A, Wang D, Akin JJ, Anderson WN, Leon MB, PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012; 366: 1686-1695.
6. Dvir D, Ben-Dor I, Barbash I, Torguson R, badr S, Sardi G, Carnicero AL, Satler L, Pichard A, Waksman R,. Severe decline in platelet count in patients treated by percutaneous aortic valve replacement is associated with a high in-hospital death rate. J Am Col Cardiol 2012; 59: E231.
7. Borz B, Durand E, Godin M, Tron C, Canville A, Litzler P-Y, Bessou J-P, Cribier A, Eltchaninoff H,. Incidence, predictors and impact of bleeding after transcatheter aortic valve implantation using the balloon-expandable Edwards prosthesis. Heart 2013; 99: 860-865.
8. Nikolsky E, Mehran R, Sadeghi HM, Grines CL, Cox DA, García E, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Fahy M, Lansky AJ, Stone GW,. Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial. JACC Cardiovasc Interv 2009; 2: 624-632.
9. Mehran R, Pocock S, Nikolsky E, Dangas GD, Clayton T, Claessen BE, Caixeta A, Feit F, Manoukian SV, White H, Bertrand M, Ohman EM, Parise H, Lansky AJ, Lincoff AM, Stone GW,. Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials. JACC Cardiovasc Interv 2011; 4: 654-664.
10. Doyle BJ, Rihal CS, Gastineau DA, Holmes DR,. Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice. J Am Coll Cardiol 2009; 53: 2019-2027.
11. Nuis R-J, Rodés-Cabau J, Sinning J-M, van Garsse L, Kefer J, Bosmans J, Dager AE, van Mieghem N, Urena M, Nickenig G, Werner N, Maessen J, Astarci P, Perez S, Benitez LM, Dumont E, van Domburg RT, de Jaegere PP,. Blood transfusion and the risk of acute kidney injury after transcatheter aortic valve implantation. Circ Cardiovasc Interv 2012; 5: 680-688.
12. ACC. TVT Registry v1.1 Coder's Data Dictionary 2012; 1-124.
13. Wang TY, Ou F-S, Roe MT, Harrington RA, Ohman EM, Gibler WB, Peterson ED., Incidence and prognostic significance of thrombocytopenia developed during acute coronary syndrome in contemporary clinical practice. Circulation 2009; 119: 2454-2462.
14. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D,. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
15. Weng H-Y, Hsueh Y-H, Messam LLM, Hertz-Picciotto I,. Methods of covariate selection: directed acyclic graphs and the change-in-estimate procedure. Am J Epidemiol 2009; 169: 1182-1190.
16. Gallet R, Seemann A, Yamamoto M, Hayat D, Mouillet G, Monin JL, Gueret P, Couetil J-P, Dubois-Randé J-L, Teiger E, Lim P,. Effect of transcatheter (via femoral artery) aortic valve implantation on the platelet count and its consequences. Am J Cardiol 2013; 111: 1619-1624.
17. Grube E, Laborde JC, Gerckens U, Felderhoff T, Sauren B, Buellesfeld L, Mueller R, Menichelli M, Schmidt T, Zickmann B, Iversen S, Stone GW,. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 2006; 114: 1616-1624.
18. Miceli A, Gilmanov D, Murzi M, Parri MS, Cerillo AG, Bevilacqua S, Farneti PA, Glauber M,. Evaluation of platelet count after isolated biological aortic valve replacement with Freedom Solo bioprosthesis. Eur J Cardiothorac Surg 2012; 41: 69-73.
19. Yerebakan C, Kaminski A, Westphal B, Kundt G, Ugurlucan M, Steinhoff G, Liebold A,. Thrombocytopenia after aortic valve replacement with the Freedom Solo stentless bioprosthesis. Int Cardiovasc Thorac Surg 2008; 7: 616-620.
20. Hilker L, Wodny M, Ginesta M, Wollert H-G, Eckel L,. Differences in the recovery of platelet counts after biological aortic valve replacement. Int Cardiovasc Thorac Surg 2009; 8: 70-73.